The diabetic heart is more sensitive to ischemic injury

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 104-112

  Paulson, Dennis J ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Contractile function; Diabetes; Myocardial ischemia; Reperfusion

Indexed keywords

FATTY ACID; GLUCOSE;

CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SODIUM CALCIUM EXCHANGE;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FATTY ACIDS; GLUCOSE; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; TIME FACTORS;

EID: 0030977837     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00018-7     Document Type: Review

References (116)

1. Kannel WB, McGee DL. Diabetes and Cardiovascular Risk Factors. The Framingham Study. Circulation 1979;59:8-13.
2. Kotler TS, Diamond GA. Myocardial ischemia in diabetic patients. Ann Intern Med 1988;109:678.
3. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study. Am Heart J 1995;130:51-58.
4. Will JC, Casper M. The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health 1996;86:576-579.
5. Paramian J, Bradley R. Acute myocardial infarction in 258 cases of diabetes. N Engl J Med 1965;273:455-461.
6. Smith J, Marcus F, Serkman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984;54:718-721.
7. Ulvenstam G, Aberg A, Bergstrand R, et al. Long-term prognosis after myocardial infarction in men with diabetes mellitus. Diabetes 1985;34:787-792.
8. Clauson BJ, Bell FT. Incidence of fatal coronary disease in nondiabetic and in diabetic persons. Arch Pathol 1949;48:105-109.
9. Stone PH, Muller JE, Hartwell T, et al. (The MILIS Study Group). The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989;14:49-57.
10. Lauria MH, Knoke JD, Wachs JS, Luria MA. Survival after recovery from acute myocardial infarction; two and five year prognostic indices. J Am Med Assoc 1979;260:3456-3460.
11. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction, the Framingham study. J Am Med Assoc 1988;260:3456-3460.
12. Beard CM, Kottke TE, Annegers JF, Ballard DJ. The Rochester Coronary Heart Disease Project. Effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc 1989;64:1471-1480.
13. Howard BV, Lee ET, Fabsitz RR, et al. Diabetes and coronary heart disease in American Indians - The Strong Heart Study. Diabetes 1996;45:S6-S13.
14. Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD. Exertional myocardial ischemia in diabetes. A quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol 1990;15:72-77.
15. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990;301:92-95.
16. Nakajima H, Kodo N, Inoue F, et al. Pivalate affects carnitine status but causes no severe metabolic changes in rat liver. J Nutr 1996;126:1683-1687.
17. Chiariello M, Indolfi C. Silent myocardial ischemia in patients with diabetes mellitus. Circulation 1996;93:2089-2091.
18. Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD. Silent myocardial ischemia. Role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993;22:1433-1437.
19. Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: A community-wide perspective. J Clin Epidemiol 1993;46:245-252.
20. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. J Am Med Assoc 1991;265:627-631.
21. Liao Y, Cooper RS, Ghali JK, Lansky D, Cao G, Lee J. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care 1993;16:708-713.
22. Herlitz J, Wognsen GB, Emanuelsson H, et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996;19:698-703.
23. Malmberg KA, Efendic S, Rydén LE. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction: A report from the multicenter trial. DIGAMI. Diabetes Care 1994;17:1007-1014.
24. Stone PH, Muller JE, Rutherford JD, Braunwald E, Jaffe AS. Ischemic heart disease and diabetic cardiomyopathy. Reply. J Am Coll Cardiol 1989;14:1586.
25. Rytter L, Froelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes mellitus. Diabetes Care 1985;8:230-234.
26. Czyzk A, Kvolewski A, Szablowska S, Alot A, Kopcznski J. Clinical course of myocardial infarction among diabetic patients. Diabetes Care 1980;3:526-529.
27. Lehto S, Pyörälä K, Miettinen H, et al. Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1994;236:291-297.
28. Orlander PR, Goff DC, Morrissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 1994;43:897-902.
29. Leor J, Nesto RW, Kloner RA. Acute myocardial infarction and diabetes mellitus. Cardiovasc Res 1993;27:1913-1915.
30. Jarrett RJ. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Survey. I. Epidemiologic followup study. Am J Epidemiol 1993;137:482.
31. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993;16:1615-1618.
32. Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction: Interaction of diabetes with other preinfarction risk factors. Diabetes 1989;38:350-357.
33. Assmann G, Schulte H. The Prospective Cardiovascular Münster (PROCAM) study. Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116(suppl)1713-1724.
34. Goldschmid MG, Barrett-Connor E, Edelstein SL, Wingard DL, Cohn BA, Herman WH. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994;89:991-997.
35. Fontbonne A, Eschwège E, Cambien F, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-304.
36. Laakso M, Lehto S, Penttilä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993;88:1421-1430.
37. Rodriguez BL, Sharp DS, Curb JD, et al. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care 1996;19:587-590.
38. Hanefeld M, Schmechel H, Julius U, Schwanebeck U. Determinants for coronary heart disease in non-insulin-dependent diabetes mellitus: Lessons from the diabetes intervention study. Diabetes Res Clin Pract 1996;30:S67-S70.
39. Simons LA, McCallum J, Friedlander Y, Simons J. Diabetes, mortality and coronary heart disease in the prospective Dubbo study of Australian elderly. Aust NZ J Med 1996;26:66-74.
40. Factor SM, Minase T, Cho S, Fein F, Capasso JM, Sonnenblick EH. Coronary microvascular abnormalities in hypertensive-diabetic rats. Am J Pathol 1984;116:9-20.
41. Assmann G, Schulte H. Diabetes mellitus and hypertension in the elderly: Concomitant hyperlipidemia and coronary heart disease risk. Am J Cardiol 1989;63:33H-37H.
42. Giles TD, Sander GE. Myocardial disease in hypertensive-diabetic patients. Am J Med 1989;87(suppl 6A):23S-28S.
43. Ford ES, DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey. I. Epidemiologic follow-up study. Am J Epidemiol 1991;133:1220-1230.
44. Kissebah AH. Intra-abdominal fat: Is it a major factor in developing diabetes and coronary artery disease? Diabetes Res Clin Pract 1996;30:S25-S30.
45. Feuvray D, Idell-Wenger JA, Neely JR. Effects of ischemia on rat myocardial function and metabolism in diabetes. Am J Physiol 1979;44:322-329.
46. Ingebretsen CG, Moreau P, Hawelu-Johnson C, Ingebretsen WR. Performance of diabetic rat hearts: effects of anoxia and increased work. Am J Physiol 1980;239:H614-H620.
47. Hearse DJ, Steward DA, Green DG. Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol 1975;7:397-415.
48. Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989;65:378-387.
49. Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta Mol Basis Dis 1994;1225:191-199.
50. Lopaschuk GD, Saddik M, Barr R, Huang L, Barder CC, Muzyke RA. Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. Am J Physiol 1992;263:E1046-E1053.
51. Paulson DJ, Kopp SJ, Peace DG, Tow JP. Improved postischemic recovery of cardiac pump function in exercise-trained diabetic rats. J Appl Physiol 1988;65:187-193.
52. Paulson DJ, Shug AL, Zhao J. Protection of the ischemic diabetic heart by L-propionylcarnitine therapy. Mol Cell Biochem 1992;116:131-137.
53. Tani M, Neely JR. Hearts from diabetic rats are more resistant to in vitro ischemia, possible role of altered calcium metabolism. Circ Res 1988;62:931-940.
54. Khandoudi N, Bernard M, Cozzone P, Feuvray D. Intracellular pH and role of Na/H exchange during ischaemia and reperfusion on normal and diabetic rat hearts. Cardiovasc Res 1990;24:873-878.
55. Khandoudi N, Bernard M, Cozzone P, Feuvray D. Mechanisms of intracellular pH regulation during postischemic reperfusion of diabetic rat hearts. Diabetes 1995;44:196-202.
56. Tilton RG, Daugherty A, Sutera SP, et al. Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits. Diabetes 1989;38:1484-1491.
57. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993;88:1273-1278.
58. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 1996;31:526-536.
59. Tosaki A, Engelman DT, Engelman RM, Das DK. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts. J Pharmacol Exp Ther 1995;275:1115-1123.
60. Kusama Y, Hearse DJ, Avkiran M. Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias. J Mol Cell Cardiol 1992;24:411-421.
61. + exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol 1990;258:H255-H261.
62. 2+ handling in ventricular myocytes isolated from diabetic rats. Am J Physiol 1996;270:H1529-H1537.
63. Cohen MV. Free radicals in ischemic and reperfusion myocardial injury: Is this the time for clinical trials? Ann Intern Med 1989;111:918-931.
64. Werns SW, Lucchesi BR. Free radicals and ischemic tissue injury. TIPS 1990;11:161-166.
65. Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat; effects of insulin treatment. Diabetes 1987;35:1014-1018.
66. Aomine M, Nobe S, Arita M. Increased susceptibility to hypoxia of prolonged action potential duration in ventricular papillary muscles from diabetic rats. Diabetes 1990;39:1485-1489.
67. Smith JM, Wahler GM. ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats. Mol Cell Biochem 1996;158:43-51.
68. Bakth S, Arena J, Lee W, et al. Arrhythmia susceptibility and myocardial composition in diabetes. J Clin Invest 1986;77:382-395.
69. Haider B, Ahmed SS, Moschos CB, Oldewurtel HA, Regan TJ. Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes. Circ Res 1977;40:577-583.
70. Forrat R, Sebbag L, Wiernsperger N, Guidollet J, Renaud S, De Lorgeril M. Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res 1993;27:1908-1912.
71. Bernier M, Curtis MJ, Hearse DJ. Ischemia-induced and reperfusion-induced arrhythmias. Importance of heart rate. Am J Physiol 1989;256:H21-H31.
72. Broderick TL, Barr RL, Quinney HA, Lopaschuk GD. Acute insulin withdrawal from diabetic BB rats decreases myocardial glycolysis during low-flow ischemia. Metabolism 1992;41:332-338.
73. Hekimian G, Khandoridi N, Feuvray D, Beigelman PM. Abnormal cardiac rhythm in diabetic rats. Life Sci 1985;37:547-551.
74. Pieper GM. Superoxide dismutase plus catalase improves postischaemic recovery in the diabetic heart. Cardiovasc Res 1988;22:916-926.
75. Paulson DJ, Schmidt MJ, Romens J, Shug AL. Metabolic and physiological differences between zero-flow and low-flow myocardial ischemia: effects of L-acetylcarnitine. Basic Res Cardiol 1984;79:551-561.
76. Shug AL, Thomsen JH, Folts JD, et al. Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys 1978;187:25-33.
77. DaTorre SD, Creer MH, Pogwizd SM, Corr PB. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 1991;23(suppl 1):11-22.
78. Mochizuke S, Ischikawa SI, Abe M. Insulin treatment and myocardial function in isolated perfused hearts from diabetic rat. Jpn Circ J 1984;48:255-265.
79. Higuchi M, Ikema S, Matsuzaki T, Hirayama K, Sakanashi M. Effects of norepinephrine on hypoperfusion-reperfusion injuries in hearts isolated from normal and diabetic rats. J Mol Cell Cardiol 1991;23:137-148.
80. Higuchi M, Ikema S, Sakanashi M. Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts. J Mol Cell Cardiol 1992;24:1125-1141.
81. Higuchi M, Miyagi K, Nakasone J, Sakanashi M. Role of high glycogen in underperfused diabetic rat hearts with added norepinephrine. J Cardiovasc Pharmacol 1995;26:899-907.
82. Takahashi M, Ueda S, Misaki H, et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994;40:817-821.
83. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-158.
84. Davies NJ, Lovlin RE, Lopaschuk GD. Effect of exogenous fatty acids on reperfusion arrhythmias in isolated working perfused hearts. Am J Physiol 1992;262:H1796-H1801.
85. Kannel WB. Role of diabetes in cardiac disease, conclusions from population studies. In: Zonaraich S, ed. Diabetes and the Heart. Springfield, IL: Thomas, 1978:97-112.
86. Crepaldi G, Nosadine R. Diabetic cardiopathy: is it a real entity? Diabetes/Metab Rev 1988;4:273-288.
87. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665-669.
88. Hausdorf G, Rieger U, Koepp P. Cardiomyopathy in childhood diabetes mellitus. incidence, time of onset, and relation to metabolic control. Int J Cardiol 1988;19:225-236.
89. Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol 1991;68:85-89.
90. Grimaldi A, Gonzalez I, Bosquet F, Komajda M. Heart damage in diabetic patients. Presse Med 1990;19:519-524.
91. Izumi T, Tsuda T, Kuwano H, Ishiguro J. Is diabetic heart muscle disease related to cardiac ischemia or autonomie neuropathy? Diabetes Res Clin Pract 1996;30:S77-S83.
92. Regan TJ, Lyons MM, Ahmed SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:885-899.
93. LeWinter MM. Diabetic cardiomyopathy: An overview. Coronary Artery Dis 1996;7:95-98.
94. Borow KM, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang RM. Myocardial mechanics in young adult patients with diabetes mellitus: Effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol 1990;15:1508-1517.
95. Bouchard A, Sanz N, Botvinick EH, et al. Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old. Am J Med 1989;87:160-166.
96. Mildenberger RR, Bar-Shlomo B, Druck MN, et al. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 1984;4:234-238.
97. Uusitupa M, Mustonen J, Laakso M, et al. Impairment of diastolic function in middle-aged Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia 1988;31:783-791.
98. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994;17:633-639.
99. Tahiliani AG, McNeill JH. Diabetes-induced abnormalities in the myocardium. Life Sci 1986;38:959-974.
100. Thompson EW, Baker JC, Kamoss SA, Anderson WH. The severity of diabetes is a major determinant of myocardial damage in the rat. Proc Soc Exp Biol Med 1991;196:230.
101. Gray RP, Yudkin JS, Patterson DL. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: A role for plasminogen activator inhibitor. Br Heart J 1993;70:530-536.
102. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41(suppl 2):26-31.
103. Kunz F, Pechlaner C, Zwierzina W-D. Platelet aggregation and nutritional status in insulin dependent diabetes mellitus. Thromb Haemost 1989;62:1147-1148.
104. Gray RP, Hendra TJ, Patterson DLH, Yudkin JS. 'Spontaneous' platelet aggregation in whole blood in diabetic and non diabetic survivors of acute myocardial infarction. Thromb Haemost 1993;70:932-936.
105. Nievelstein PFEM, Sixma JJ, Ottenhof-Rovers M, Wynne HJ, De Groot PG, Banga JD. Platelet adhesion and aggregate formation in type I diabetes under flow conditions. Diabetes 1991;40:1410-1417.
106. Vicari AM, Macagni A, Pozza G. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients. Horm Metab Res 1989;21:616-618.
107. Montrucchio G, Alloatti G, Mariano F, et al. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol 1990;137:71-83.
108. Yudkin JS. Coronary heart disease in diabetes mellitus. Three new risk factors and a unifying hypothesis. J Intern Med 1995;238:21-30.
109. Panes J, Kurose I, Rodriguez-Vaca MD, et al. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 1996;93:161-167.
110. Heijnis JB, Mathy M-J, Van Zwieten PA. Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats. J Cardiovasc Pharmacol 1991;17:983-989.
111. Vogel WM, Apstein CS. Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts. Circ Res 1988;62:975-982.
112. Beatch GN, McNeill JH. Ventricular arrhythmias following coronary artery occlusion in the streptozotocin diabetic rat. Can J Physiol Pharmacol 1988;66:312-317.
113. Piji AJ, Hendriks MGC, Kam KL, Pfaffendorf M, Van Zwieten PA. Antiischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic, and hypertensive rats. J Cardiovasc Pharmacol 1994;23:379-386.
114. Pieper GM, Gross GJ. Diabetes alters postischemic response to a prostacyclin mimetic. Am J Physiol 1989;256:H1353-H1360.
115. Pieper GM. Arachidonic acid causes postischemic dysfunction in control but not diabetic hearts. Am J Physiol Heart 1990;258:H923-H929.
116. Pieper GM, Gross GJ. Differential response of postischemic diabetic myocardium to a thromboxane-mimetic. Eicosanoids 1990;3:127-133.